FERLİÇOLAK, L. Et Al. 2023. EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY. ACTA ENDOCRINOLOGICA-BUCHAREST , vol.19, no.1 , 49-53.

FERLİÇOLAK, L., YILDIZ, B., & ALTINTAŞ, N. D., (2023). EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY. ACTA ENDOCRINOLOGICA-BUCHAREST , vol.19, no.1, 49-53.

FERLİÇOLAK, LEYLA, BURÇAK YILDIZ, And NERİMAN DEFNE ALTINTAŞ. "EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY," ACTA ENDOCRINOLOGICA-BUCHAREST , vol.19, no.1, 49-53, 2023

FERLİÇOLAK, LEYLA Et Al. "EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY." ACTA ENDOCRINOLOGICA-BUCHAREST , vol.19, no.1, pp.49-53, 2023

FERLİÇOLAK, L. YILDIZ, B. And ALTINTAŞ, N. D. (2023) . "EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY." ACTA ENDOCRINOLOGICA-BUCHAREST , vol.19, no.1, pp.49-53.

@article{article, author={LEYLA FERLİÇOLAK Et Al. }, title={EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY}, journal={ACTA ENDOCRINOLOGICA-BUCHAREST}, year=2023, pages={49-53} }